| Neal D Kurtti, MD | |
|
255 Lafayette Ave, Suffern, NY 10901-4812 | |
| (845) 368-5039 | |
| (845) 368-5327 |
| Full Name | Neal D Kurtti |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 37 Years |
| Location | 255 Lafayette Ave, Suffern, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326086273 | NPI | - | NPPES |
| 01251550 | Medicaid | NY | |
| 0016110 | Medicaid | NJ | |
| P01043481 | Other | NJ | RAILROAD MEDICARE |
| 050017338 | Other | NY | RAILROAD MEDICARE |
| 102786284 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 180952-1 (New York) | Primary |
| 207L00000X | Anesthesiology | 25MA05987400 (New Jersey) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ny Nj Anesthesia Llc | 9537447677 | 5 |
| Ramapo Anesthesiologists, Pc | 3476444373 | 73 |
News Archive
Despite progress in decoding the genome, scientists estimate that fully 95 percent of our DNA represents dark, unknown territory. In the October 1 issue of the journal Cell researchers at The Wistar Institute shed new light on the genetic unknown with the discovery of the ability of long non-coding RNA (ncRNA) to promote gene expression.
Physician-researchers from the Cardiac Center at The Children's Hospital of Philadelphia presented new findings on pediatric cardiovascular disease at the American Heart Association's Scientific Sessions 2012 in Los Angeles.
AcuFocus is pleased to announce they received approval from the Korean Food and Drug Administration (KFDA) for the KAMRA inlay, making this revolutionary treatment option for near vision loss available to the Korean population.
The U.S. Food and Drug Administration today approved Elzonris (tagraxofusp-erzs) infusion for the treatment of blastic plasmacytoid dendritic cell neoplasm in adults and in pediatric patients, two years of age and older.
"I've always believed that bringing together the world's brightest minds to help solve the significant and complex crises we face as a global society is the best way to effect change in the world and that is how I envision re-imagining the future of Global Health," entrepreneur Naveen Jain, founder of World Innovation Institute, Moon Express, inome, and InfoSpace, writes in a Forbes opinion piece.
› Verified 8 days ago
| Entity Name | Ramapo Valley Anesthesia Associates,llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154576387 PECOS PAC ID: 4486711413 Enrollment ID: O20090319000008 |
News Archive
Despite progress in decoding the genome, scientists estimate that fully 95 percent of our DNA represents dark, unknown territory. In the October 1 issue of the journal Cell researchers at The Wistar Institute shed new light on the genetic unknown with the discovery of the ability of long non-coding RNA (ncRNA) to promote gene expression.
Physician-researchers from the Cardiac Center at The Children's Hospital of Philadelphia presented new findings on pediatric cardiovascular disease at the American Heart Association's Scientific Sessions 2012 in Los Angeles.
AcuFocus is pleased to announce they received approval from the Korean Food and Drug Administration (KFDA) for the KAMRA inlay, making this revolutionary treatment option for near vision loss available to the Korean population.
The U.S. Food and Drug Administration today approved Elzonris (tagraxofusp-erzs) infusion for the treatment of blastic plasmacytoid dendritic cell neoplasm in adults and in pediatric patients, two years of age and older.
"I've always believed that bringing together the world's brightest minds to help solve the significant and complex crises we face as a global society is the best way to effect change in the world and that is how I envision re-imagining the future of Global Health," entrepreneur Naveen Jain, founder of World Innovation Institute, Moon Express, inome, and InfoSpace, writes in a Forbes opinion piece.
› Verified 8 days ago
| Entity Name | Ny Nj Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396299582 PECOS PAC ID: 9537447677 Enrollment ID: O20161025001805 |
News Archive
Despite progress in decoding the genome, scientists estimate that fully 95 percent of our DNA represents dark, unknown territory. In the October 1 issue of the journal Cell researchers at The Wistar Institute shed new light on the genetic unknown with the discovery of the ability of long non-coding RNA (ncRNA) to promote gene expression.
Physician-researchers from the Cardiac Center at The Children's Hospital of Philadelphia presented new findings on pediatric cardiovascular disease at the American Heart Association's Scientific Sessions 2012 in Los Angeles.
AcuFocus is pleased to announce they received approval from the Korean Food and Drug Administration (KFDA) for the KAMRA inlay, making this revolutionary treatment option for near vision loss available to the Korean population.
The U.S. Food and Drug Administration today approved Elzonris (tagraxofusp-erzs) infusion for the treatment of blastic plasmacytoid dendritic cell neoplasm in adults and in pediatric patients, two years of age and older.
"I've always believed that bringing together the world's brightest minds to help solve the significant and complex crises we face as a global society is the best way to effect change in the world and that is how I envision re-imagining the future of Global Health," entrepreneur Naveen Jain, founder of World Innovation Institute, Moon Express, inome, and InfoSpace, writes in a Forbes opinion piece.
› Verified 8 days ago
| Entity Name | Lakes Anesthesia |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154862738 PECOS PAC ID: 8123384997 Enrollment ID: O20200204002312 |
News Archive
Despite progress in decoding the genome, scientists estimate that fully 95 percent of our DNA represents dark, unknown territory. In the October 1 issue of the journal Cell researchers at The Wistar Institute shed new light on the genetic unknown with the discovery of the ability of long non-coding RNA (ncRNA) to promote gene expression.
Physician-researchers from the Cardiac Center at The Children's Hospital of Philadelphia presented new findings on pediatric cardiovascular disease at the American Heart Association's Scientific Sessions 2012 in Los Angeles.
AcuFocus is pleased to announce they received approval from the Korean Food and Drug Administration (KFDA) for the KAMRA inlay, making this revolutionary treatment option for near vision loss available to the Korean population.
The U.S. Food and Drug Administration today approved Elzonris (tagraxofusp-erzs) infusion for the treatment of blastic plasmacytoid dendritic cell neoplasm in adults and in pediatric patients, two years of age and older.
"I've always believed that bringing together the world's brightest minds to help solve the significant and complex crises we face as a global society is the best way to effect change in the world and that is how I envision re-imagining the future of Global Health," entrepreneur Naveen Jain, founder of World Innovation Institute, Moon Express, inome, and InfoSpace, writes in a Forbes opinion piece.
› Verified 8 days ago
| Entity Name | Quality Anesthesia Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962033993 PECOS PAC ID: 0648607788 Enrollment ID: O20200302000188 |
News Archive
Despite progress in decoding the genome, scientists estimate that fully 95 percent of our DNA represents dark, unknown territory. In the October 1 issue of the journal Cell researchers at The Wistar Institute shed new light on the genetic unknown with the discovery of the ability of long non-coding RNA (ncRNA) to promote gene expression.
Physician-researchers from the Cardiac Center at The Children's Hospital of Philadelphia presented new findings on pediatric cardiovascular disease at the American Heart Association's Scientific Sessions 2012 in Los Angeles.
AcuFocus is pleased to announce they received approval from the Korean Food and Drug Administration (KFDA) for the KAMRA inlay, making this revolutionary treatment option for near vision loss available to the Korean population.
The U.S. Food and Drug Administration today approved Elzonris (tagraxofusp-erzs) infusion for the treatment of blastic plasmacytoid dendritic cell neoplasm in adults and in pediatric patients, two years of age and older.
"I've always believed that bringing together the world's brightest minds to help solve the significant and complex crises we face as a global society is the best way to effect change in the world and that is how I envision re-imagining the future of Global Health," entrepreneur Naveen Jain, founder of World Innovation Institute, Moon Express, inome, and InfoSpace, writes in a Forbes opinion piece.
› Verified 8 days ago
| Entity Name | Bay Anesthesia |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063151546 PECOS PAC ID: 0446639306 Enrollment ID: O20220623000548 |
News Archive
Despite progress in decoding the genome, scientists estimate that fully 95 percent of our DNA represents dark, unknown territory. In the October 1 issue of the journal Cell researchers at The Wistar Institute shed new light on the genetic unknown with the discovery of the ability of long non-coding RNA (ncRNA) to promote gene expression.
Physician-researchers from the Cardiac Center at The Children's Hospital of Philadelphia presented new findings on pediatric cardiovascular disease at the American Heart Association's Scientific Sessions 2012 in Los Angeles.
AcuFocus is pleased to announce they received approval from the Korean Food and Drug Administration (KFDA) for the KAMRA inlay, making this revolutionary treatment option for near vision loss available to the Korean population.
The U.S. Food and Drug Administration today approved Elzonris (tagraxofusp-erzs) infusion for the treatment of blastic plasmacytoid dendritic cell neoplasm in adults and in pediatric patients, two years of age and older.
"I've always believed that bringing together the world's brightest minds to help solve the significant and complex crises we face as a global society is the best way to effect change in the world and that is how I envision re-imagining the future of Global Health," entrepreneur Naveen Jain, founder of World Innovation Institute, Moon Express, inome, and InfoSpace, writes in a Forbes opinion piece.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Neal D Kurtti, MD 100 Route 59, Suite 105, Suffern, NY 10901-4927 Ph: (845) 357-5775 | Neal D Kurtti, MD 255 Lafayette Ave, Suffern, NY 10901-4812 Ph: (845) 368-5039 |
News Archive
Despite progress in decoding the genome, scientists estimate that fully 95 percent of our DNA represents dark, unknown territory. In the October 1 issue of the journal Cell researchers at The Wistar Institute shed new light on the genetic unknown with the discovery of the ability of long non-coding RNA (ncRNA) to promote gene expression.
Physician-researchers from the Cardiac Center at The Children's Hospital of Philadelphia presented new findings on pediatric cardiovascular disease at the American Heart Association's Scientific Sessions 2012 in Los Angeles.
AcuFocus is pleased to announce they received approval from the Korean Food and Drug Administration (KFDA) for the KAMRA inlay, making this revolutionary treatment option for near vision loss available to the Korean population.
The U.S. Food and Drug Administration today approved Elzonris (tagraxofusp-erzs) infusion for the treatment of blastic plasmacytoid dendritic cell neoplasm in adults and in pediatric patients, two years of age and older.
"I've always believed that bringing together the world's brightest minds to help solve the significant and complex crises we face as a global society is the best way to effect change in the world and that is how I envision re-imagining the future of Global Health," entrepreneur Naveen Jain, founder of World Innovation Institute, Moon Express, inome, and InfoSpace, writes in a Forbes opinion piece.
› Verified 8 days ago
Kareem Eltaki Eltaki, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 255 Lafayette Ave, Suffern, NY 10901 Phone: 845-368-5000 Fax: 845-357-5777 | |
Dr. Jane K Kim, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 255 Lafayette Ave, Good Samaritan Hospital, Suffern, NY 10901 Phone: 845-368-5000 Fax: 845-357-5777 | |
Stephanie Moura, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 255 Lafayette Ave, Suffern, NY 10901 Phone: 845-357-5775 Fax: 845-357-5777 | |
Dr. Bernard Baez, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 255 Lafayette Ave, Suffern, NY 10901 Phone: 845-368-5039 Fax: 845-357-5777 | |
Dr. Brian Steven Philip, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 255 Lafayette Ave, Suffern, NY 10901 Phone: 845-368-5000 Fax: 845-357-5777 | |
Tracey Jay Krzanowski, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 Route 59, Suite 105, Suffern, NY 10901 Phone: 845-357-5775 Fax: 845-357-5777 | |
Miss Jennifer Narciso Alt, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 255 Lafayette Ave, Suffern, NY 10901 Phone: 845-368-5039 Fax: 845-368-5327 |